OrthoPediatrics Corp. Revenue 2015–2025

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

OrthoPediatrics Corp. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

OrthoPediatrics Corp. revenue for the quarter ending March 31, 2026 was 59.4 M, a 13.26% increase year-over-year.
OrthoPediatrics Corp. revenue for the twelve months ending March 31, 2026 was 234.1 M, a 21.91% increase year-over-year.
OrthoPediatrics Corp. annual revenue for 2025 was 236.3 M, a 15.45% increase from 2024.
OrthoPediatrics Corp. annual revenue for 2024 was 204.7 M, a 37.65% increase from 2023.
OrthoPediatrics Corp. annual revenue for 2023 was 148.7 M, a 21.62% increase from 2022.
OrthoPediatrics Corp. annual revenue for 2022 was 122.3 M.

Revenue

TRAILING 12 MONTHS · $B

QUARTERLY · $B

YEAR-OVER-YEAR GROWTH · %

OrthoPediatrics Corp. (KIDS) — Frequently Asked Questions

OrthoPediatrics Corp. (KIDS) is a publicly traded US company. It has a market capitalization of $433M. In fiscal 2025 it reported revenue of $236M and net income of -$40M. Explore KIDS's stock price, financial statements, earnings history, margins and key ratios below.

What is OrthoPediatrics Corp.'s market cap?

OrthoPediatrics Corp. (KIDS) has a market capitalization of $433M.

What is the KIDS stock price?

KIDS trades at $18.46 (-0.16% on the day).

How much revenue does OrthoPediatrics Corp. make?

OrthoPediatrics Corp. reported revenue of $236M in fiscal 2025.

Is KIDS profitable?

In fiscal 2025, OrthoPediatrics Corp. reported net income of -$40M.